We are live on ! Find out more
AI

Acuitas Investments Portfolio holdings

AUM $1.43M
1-Year Est. Return 17.52%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+17.52%
3 Year Est. Return
+145.17%
5 Year Est. Return
+267.61%
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$6.73M
Cap. Flow
-$15.5M
Cap. Flow %
-7.83%
Top 10 Hldgs %
22.77%
Holding
139
New
22
Increased
48
Reduced
35
Closed
16

Top Buys

Rank Stock Value
1
EQX icon
Equinox Gold
EQX
+$3.26M
2
INVX
Innovex International
INVX
+$1.57M
3
CATO icon
Cato Corp
CATO
+$1.55M
4
AAOI icon
Applied Optoelectronics
AAOI
+$1.41M
5
FSP
Franklin Street Properties
FSP
+$1.35M

Top Sells

Rank Stock Value
1
TBBK icon
The Bancorp
TBBK
+$4.41M
2
FONR
Fonar
FONR
+$3.61M
3
CHS
Chicos FAS, Inc.
CHS
+$3.23M
4
FC icon
Franklin Covey
FC
+$2.93M
5
SENEA icon
Seneca Foods Class A
SENEA
+$2.93M

Sector Composition

Rank Sector Weight
1 Healthcare 17.84%
2 Industrials 17.27%
3 Consumer Discretionary 13.61%
4 Technology 10.93%
5 Materials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPI icon
76
Intrepid Potash
IPI
$469M
$794K 0.4%
+38,068
New +$760K
WHWK
77
Whitehawk Therapeutics
WHWK
$271M
$744K 0.38%
+318,139
New +$613K
NTGR icon
78
NETGEAR
NTGR
$635M
$742K 0.37%
47,062
+5,178
+12% +$75.4K
KLRS
79
Kalaris Therapeutics
KLRS
$96.8M
$740K 0.37%
+42,591
New +$695K
BOLT icon
80
Bolt Biotherapeutics
BOLT
$7.78M
$725K 0.37%
25,898
+2,925
+13% +$67.7K
NXTC icon
81
NextCure
NXTC
$26.7M
$717K 0.36%
26,805
-4,262
-14% -$73.4K
EGAN icon
82
eGain
EGAN
$201M
$714K 0.36%
110,709
+43,185
+64% +$296K
IVAC
83
DELISTED
Intevac Inc
IVAC
$706K 0.36%
183,916
+19,648
+12% +$78.7K
LENZ
84
LENZ Therapeutics
LENZ
$168M
$703K 0.35%
31,488
+3,691
+13% +$76.7K
KOD icon
85
Kodiak Sciences
KOD
$2.84B
$693K 0.35%
131,803
-102,289
-44% -$501K
CMRX
86
DELISTED
Chimerix, Inc.
CMRX
$673K 0.34%
635,261
+318,680
+101% +$332K
OKUR
87
OnKure Therapeutics
OKUR
$168M
$671K 0.34%
+40,405
New +$667K
TATT icon
88
TAT Technologies
TATT
$515M
$665K 0.34%
54,710
+8,230
+18% +$99.4K
ASMB icon
89
Assembly Biosciences
ASMB
$529M
$661K 0.33%
49,732
+27,600
+125% +$322K
SEER icon
90
Seer Inc
SEER
$120M
$644K 0.32%
338,949
+145,352
+75% +$261K
PASG icon
91
Passage Bio
PASG
$14.1M
$634K 0.32%
23,465
+2,578
+12% +$62K
KZR
92
DELISTED
Kezar Life Sciences
KZR
$623K 0.31%
+69,083
New +$629K
SERA icon
93
Sera Prognostics
SERA
$81.1M
$601K 0.3%
66,044
-55,214
-46% -$438K
PMVP icon
94
PMV Pharmaceuticals
PMVP
$63.5M
$598K 0.3%
+351,875
New +$657K
KRON
95
DELISTED
Kronos Bio
KRON
$573K 0.29%
441,106
+113,130
+34% +$129K
ACRS icon
96
Aclaris Therapeutics
ACRS
$869M
$572K 0.29%
+461,663
New +$551K
IMA
97
ImageneBio Inc
IMA
$64.6M
$565K 0.28%
+33,146
New +$604K
AVNW icon
98
Aviat Networks
AVNW
$273M
$540K 0.27%
14,073
– –
ITI
99
DELISTED
Iteris, Inc.
ITI
$524K 0.26%
105,995
-439,985
-81% -$2.17M
ASTC icon
100
Astrotech Corp
ASTC
$17.8M
$522K 0.26%
59,237
-3,333
-5% -$26.5K
2 3
4
5 6

Similar funds

SH
Svenska Handelsbanken Stockholm, Sweden $1.38M AUM 61.04% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.48M AUM 24.97% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
DILIH
Dai-ichi Life International Holdings Tokyo, Japan $1.52M AUM
SCM
SVB Capital Management Menlo Park, California $2.07M AUM 23.37% 1-Year Est. Return
HB
Huntington Bancshares Columbus, Ohio $777K AUM
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
PA
Parafestas Anastasios $657K AUM 27.26% 1-Year Est. Return

Acuitas Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Acuitas Investments held 139 positions worth $198M, up 3.5% from $192M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Acuitas Investments withdrew a net $15.5M in Q1 2024, closing 16 positions and reducing 35 holdings. Its most notable exit was The Bancorp, an estimated $4.41M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Acuitas Investments opened a new position in Equinox Gold worth $4.23M.

  • Acuitas Investments's largest Q1 2024 buy was Equinox Gold: 702,314 shares worth $4.23M.
  • Acuitas Investments added most to Innovex International in Q1 2024, an estimated $1.57M increase.
  • Acuitas Investments's biggest Q1 2024 reduction was Fonar, cutting an estimated $3.61M.
  • Acuitas Investments fully exited The Bancorp in Q1 2024, selling an estimated $4.41M.
  • Acuitas Investments's ten largest holdings make up 23% of its $198M portfolio in Q1 2024.
  • Acuitas Investments opened 22 new positions and closed 16 in Q1 2024.
  • Acuitas Investments's portfolio value rose 3.5% quarter-over-quarter to $198M.

Based on Acuitas Investments's 13F filing for Q1 2024, filed 10 May 2024.